Device Surgery

Arista Ah Flexitip

Payments companies reported to CMS as associated with Arista Ah Flexitip. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$566Kassociated payments (2023-2025)

4,739clinicians with associated payments

4companies reporting

By year

2023 $234K

2024 $332K

Payments reported as associated with Arista Ah Flexitip, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Orthopaedic Surgery $77K

Thoracic Surgery (Cardiothoracic Vascular Surgery) $64K

Surgery $61K

Gynecologic Oncology $58K

Adult Reconstructive Orthopaedic Surgery $52K

Obstetrics & Gynecology $38K

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Arista Ah Flexitip

These are the largest totals companies reported as associated with Arista Ah Flexitip. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

Clinician	Location	Specialty	Associated payments (2023-2025)
Kristopher Lybarger	Kansas City, MO	Gynecologic Oncology	$53,658.40
Javad Parvizi	Philadelphia, PA	Adult Reconstructive Orthopaedic Surgery	$42,809.17
Jonathan Christy	Savannah, GA	Orthopaedic Surgery	$20,203.75
Ara Klijian	Murrieta, CA	Thoracic Surgery (Cardiothoracic Vascular Surgery)	$18,246.05
Richard Thompson	Lincoln, NE	Thoracic Surgery (Cardiothoracic Vascular Surgery)	$16,530.74
Gary Jett	Plano, TX	Thoracic Surgery (Cardiothoracic Vascular Surgery)	$6,960.43
John Fischer	Philadelphia, PA	Plastic Surgery	$6,822.93
Jacques Fontaine	Tampa, FL	Thoracic Surgery (Cardiothoracic Vascular Surgery)	$5,035.43
Pedro Maria	Bronx, NY	Urology	$4,144.60
Sean Mcmillan	Burlington, NJ	Sports Medicine (Orthopaedic Surgery)	$3,241.36

Prescribed Arista Ah Flexitip?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

What this means, and what it doesn't

These payments are legal and common. Drug and device makers routinely pay for meals at educational events, consulting, speaking, travel, and research. Companies are required by federal law to report them; that's why this data exists.
A payment is not evidence of wrongdoing. Most clinicians who accept industry payments provide excellent care. Research payments in particular often reflect participation in clinical trials.
Context beats raw numbers. A few hundred dollars in sandwiches over several years is typical. What's worth understanding is scale, source, and purpose, which is what this page shows.
The data comes from companies, not doctors. Figures are "as reported to CMS" by the paying companies. Clinicians can dispute records through CMS's official process.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.